Rahman and colleagues investigated a cohort of 923 breast cancer cases of which 10 individuals presented with mono-allelic truncating PALB2 mutations, while a set of 1,084 controls harboured no truncating mutations. The gene discussed is PALB2; the disease is breast cancer.